EP3551761
HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.12.2016EP published:
16.3.2022EP application number:
16809752.5
EPO information:
European Patent Register
Max expiry date:
6.12.2036
Title in English:
HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPYLanguage of the patent:
English
Timeline
Today
7.12.2016EP application
16.3.2022EP Publication
Owner
Name:
Fundació Privada Institut d'Investigació Oncològica de Vall-HebronAddress:
C/ Natzaret 115, 08035 Barcelona, ES
Name:
Fundación SoltiAddress:
C. Balmes 89 3º 7ª, 08008 Barcelona, ES
Name:
Fundación para el Fomento de la Investigación Sanitaria y Biomedica de la comunitat ValencianaAddress:
Avda. Catalunya, 21, 46020 Valencia, ES
Name:
Hospital Clínic de BarcelonaAddress:
C. Villarroel 170, 08036 Barcelona, ES
Inventor
Name:
PRAT APARICIO, AleixAddress:
08036 Barcelona, ES
Name:
CORTÉS CASTÁN, JavierAddress:
08035 Barcelona, ES
Name:
LLOMBART CUSSAC, AntonioAddress:
46020 Valencia, ES
Classification
Categories:
C12Q 1/68